Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.
about
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulationExpression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid siteIntracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surfaceIsolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytesMultimeric CD4 binding exhibited by human and simian immunodeficiency virus envelope protein dimersPathogenesis of human immunodeficiency virus infectionComplex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamineFunctional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomainBiosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transportThe role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cellsA Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV ImmunogenA Single-Cell Platform for Monitoring Viral Proteolytic Cleavage in Different Cellular CompartmentsFurin Processing and Proteolytic Activation of Semliki Forest VirusHuman fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivoAntigenic structure of envelope glycoprotein E1 of hog cholera virusBiosynthesis, maturation, and acid activation of the Semliki Forest virus fusion proteinFusion function of the Semliki Forest virus spike is activated by proteolytic cleavage of the envelope glycoprotein precursor p62Crystal Structure of a Soluble Cleaved HIV-1 Envelope TrimerApolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionEndoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycoproteins in CHO-K1 cellsFurin is important but not essential for the proteolytic maturation of gp160 of HIV-1Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptaseAntiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseApolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formationSynergistic inhibition of human immunodeficiency virus type 1 and type 2 replication in vitro by castanospermine and 3'-azido-3'-deoxythymidineInhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replicationAn assay to monitor HIV-1 protease activity for the identification of novel inhibitors in T-cellsFangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processingA Novel Two-Tag System for Monitoring Transport and Cleavage through the Classical Secretory Pathway - Adaptation to HIV Envelope ProcessingCharacterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusionFunctional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1)α-Glucosidase inhibitors as potential broad based anti-viral agentsThe pathogenesis of influenza in humans.HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine developmentC-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site.
P2860
Q24537689-786F2F2A-059B-4E64-BE42-5F9FE4EDEA8FQ24555668-D7118547-FCD6-45D4-9B24-6142AE370F88Q24556563-69C34B3E-23C5-46D3-86E1-3958C956EE38Q24597118-C12AB258-37ED-4262-93AA-E623C1DBC047Q24621842-D05F16A3-7DF3-4449-91E4-49C319E04754Q24630280-3680B3E1-83C7-48F1-990F-8C40F87ECB50Q24634681-14FC1A7C-E67E-4DF4-8F71-D85F8FB2D0B0Q24644271-FD598092-7C63-4368-9183-2420CB20FB2AQ24645233-19D781B0-C250-4A1C-8C8C-A24791E3A9D6Q24646043-239A6A32-DE15-46C8-84A7-20D253724CADQ24678833-345B7814-57ED-488D-8CF1-3B2B253C07AEQ27302081-6CE80BCB-E67E-4539-95DF-9054DE7C32A8Q27468663-826004E1-0724-4161-A48D-B8220A8A66D7Q27473344-7C3CE68A-39AA-4C26-9BC7-B2159A5BC679Q27482438-8373F809-B23C-473B-A8BA-85EBD7B904C3Q27485990-A6BEC0F4-05EB-4F1C-ADEA-A720063B15BAQ27486494-7FA2AA77-B579-4D23-B015-180427024C9EQ27486570-43FCBBBA-D54A-4600-8030-7C6136206476Q27680496-02C65468-D896-420C-9D41-149C58B5BDB5Q28284354-A778210C-91F5-4223-B105-2778A4238A61Q28301298-1C5C43D7-99B6-4995-83B9-47923847BAD7Q28302730-BB0FA786-6BED-4692-B0D4-A753A46B6E27Q28324219-419A03B0-94D3-4E01-B7CC-8357A5B54581Q28325705-B9E5B9BE-92B7-4D86-BDAB-0B4A2EF054DFQ28330684-DAE9D6A2-5C19-4C54-8706-71DF81973D92Q28354620-A09DB616-2C95-4DAF-8158-27F7BC0A08E4Q28368050-55D7BB95-7982-4357-A578-889EAED0F4E5Q28368051-7F0DECC2-6760-4EAF-B88A-7F7CEF65B163Q28474218-5D8D4857-8714-45FF-B322-36CE77195120Q28480389-181C7BBF-E0AD-4C3C-9887-9C883714CBE0Q28533980-78F0395C-29DC-4BE8-801B-E467E1FF1E52Q28646771-B3FB833D-8DD4-48FF-9B19-31889D6D4A51Q28646837-ACCF727D-BFC0-49D3-8F2C-208210B40BAEQ28743199-03C37583-7592-49E6-8E05-099550743562Q29036682-FB72F89E-2C9C-4359-BF07-EDAAC59E74AEQ30328490-90D502D9-A2B8-4DBA-AF6B-5C28BCCB4494Q30355260-D6A48404-E452-4AFE-B1FA-4267F4F438BDQ30422545-0D820D8B-B035-40EA-A96B-BEEDE6A1A932Q30447936-BB3FE6F3-A8F3-4CDA-8FD4-0316EDCC722CQ30683183-F277C287-1C82-429F-A790-379C44F5A910
P2860
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Endoproteolytic cleavage of gp ...... human immunodeficiency virus.
@en
type
label
Endoproteolytic cleavage of gp ...... human immunodeficiency virus.
@en
prefLabel
Endoproteolytic cleavage of gp ...... human immunodeficiency virus.
@en
P2093
P1433
P1476
Endoproteolytic cleavage of gp ...... human immunodeficiency virus.
@en
P2093
Feinberg MB
Lieberman M
Weissman IL
P356
10.1016/0092-8674(88)90487-4
P407
P577
1988-04-01T00:00:00Z